2013
DOI: 10.5897/jmld12.009
|View full text |Cite
|
Sign up to set email alerts
|

Serum levels of glycosaminoglycans (GAGs) and insulin like growth factor-1 (IGF-1) as diagnostic markers for early hepatocellular carcinoma in cirrhotic patients with or without diabetes

Abstract: The significance of serum levels of glycosaminoglycans (GAGs) and insulin like growth factor-1 (IGF-1) in early screening of hepatocellular carcinoma in cirrhotic patients was evaluated. The effect of diabetes on GAGs and IGF-1 levels was also estimated. Fifty cirrhotic patients with early stage Hepatocellular carcinoma (HCC) (22 were diabetic), thirty control cirrhotic patients without HCC (11 were diabetic) and twenty normal control subjects, were enrolled to the study. Serum α-fetoprotein (AFP), the commonl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
1
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 57 publications
2
1
0
Order By: Relevance
“…Our results were in agreement with other reports demonstrating low IGF-1 levels in HCC patients (Ibrahim, Attia, Rabea, & El-Gayar, 2013). Reduced IGF-1 could be due to the increased oxidative damage in cirrhosis and HCC, leading to increased damage of parenchymal liver cell and decrease in IGF-1 synthesis (Ibrahim, Attia, Rabea, & El-Gayar, 2013). Another explanation was provided by Mazziotti et al (2002), who proposed that IGF-1 was low in HCC patients because of reduced ability of growth hormone to stimulate IGF-1 synthesis due to either a reduction of growth hormone receptors number in the diseased liver or a post receptor defect.…”
Section: Discussionsupporting
confidence: 94%
See 1 more Smart Citation
“…Our results were in agreement with other reports demonstrating low IGF-1 levels in HCC patients (Ibrahim, Attia, Rabea, & El-Gayar, 2013). Reduced IGF-1 could be due to the increased oxidative damage in cirrhosis and HCC, leading to increased damage of parenchymal liver cell and decrease in IGF-1 synthesis (Ibrahim, Attia, Rabea, & El-Gayar, 2013). Another explanation was provided by Mazziotti et al (2002), who proposed that IGF-1 was low in HCC patients because of reduced ability of growth hormone to stimulate IGF-1 synthesis due to either a reduction of growth hormone receptors number in the diseased liver or a post receptor defect.…”
Section: Discussionsupporting
confidence: 94%
“…Our results were in agreement with other reports demonstrating low IGF-1 levels in HCC patients (Ibrahim, Attia, Rabea, & El-Gayar, 2013). Reduced IGF-1 could be due to the increased oxidative damage in cirrhosis and HCC, leading to increased damage of parenchymal liver cell and decrease in IGF-1 synthesis (Ibrahim, Attia, Rabea, & El-Gayar, 2013).…”
Section: Discussionsupporting
confidence: 93%
“…In this context, applying a simple, noninvasive, low cost marker for liver reserve assessment will be helpful. [ 32 ].…”
Section: Discussionmentioning
confidence: 99%